CSS LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.9K Buy
+40
New +$10.2K ﹤0.01% 963
2025
Q4
– Sell
-2,010
Closed -$917K – 1014
2025
Q3
$917K Buy
+2,010
New +$818K 0.04% 352
2024
Q4
– Sell
-7,500
Closed -$2.06M – 964
2024
Q3
$2.06M Buy
7,500
+6,800
+971% +$1.77M 0.09% 159
2024
Q2
$170K Buy
+700
New +$111K 0.01% 704
2022
Q4
– Sell
-4,613
Closed -$924K – 939
2022
Q3
$924K Buy
+4,613
New +$880K 0.04% 363

Other funds holding ALNY

CSS LLC's ALNY Position: Q3 2026 in Review

CSS LLC opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 40 shares worth $9.9K. The stake represents ﹤0.01% of the portfolio and ranks #963 among its holdings. This is a return to the name: CSS LLC previously reported a position in ALNY as recently as Q3 2025.

CSS LLC first reported a position in ALNY in Q3 2022 and has held it in 5 quarters since. The position peaked at $2.06M in Q3 2024. 722 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • CSS LLC held 40 shares of Alnylam Pharmaceuticals worth $9.9K as of Q3 2026.
  • Alnylam Pharmaceuticals was a new CSS LLC position in Q3 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of CSS LLC's portfolio in Q3 2026, its #963 holding.
  • CSS LLC first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
  • CSS LLC's Alnylam Pharmaceuticals position peaked at $2.06M in Q3 2024.
  • 722 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on CSS LLC's 13F filing for Q3 2026, filed 16 Nov 2026.